Eminent Immunologist Explains Why “Delta” Variant is Nothing to Worry About, But the mRNA “Vac

Joined
Apr 11, 2010
Messages
2,958
Eminent Immunologist Explains Why “Delta” Variant is Nothing to Worry About, But the mRNA “Vac


https://coronanews123.wordpress.com/2021/08/03/eminent-immunologist-explains-why-delta-variant-is-nothing-to-worry-about-but-the-mrna-vaccines-are-terrifying/


Dr. Sucharit Bhakdi
is Professor emeritus of the University of Mainz, where he served as the chair of the department of medical microbiology and hygiene from 1991 to 2012. From 1990 to 2012, he served as Editor in Chief of Medical Microbiology and Immunology. In 2001 he was awarded the Aronson Prize for achievements in microbiology and immunology.


Dr. Bhakdi is the co-author of “Corona, False Alarm? Facts and Figures,” an Amazon bestseller since its publication in October 2020. In this presentation Dr. Bhakdi explains the biology of the terrifying possible dangers of the Pfizer/Moderna mRNA vaccines, and how their risk is unnecessary.


Dr. Sucharit Bhakdi, Professor emeritus of the University of Mainz (view at Bitchute)

CLICK ON IMAGE TO WATCH
 
UNCONFIRMED

Nicotine (and perhaps B vitamins such as Nicotinic Acid or Nicotinamide?) is claimed to mitigate the effects of the frankenshot:

8lDmQCNY.png
 
Efficacy of Nicotine in Preventing COVID-19 Infection (NICOVID-PREV)

https://clinicaltrials.gov/ct2/show/NCT04583410

The coronavirus disease (COVID-19) epidemic represents a major therapeutic challenge. The highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) and the long duration of the disease have led to a massive influx of patients admitted in health services and intensive care units.

According to current knowledge, there are no treatments that prevent the spread of the infection, especially in exposed populations, or the disease progression to a severe form.

Daily active smokers are infrequent among outpatients or hospitalized patients with COVID-19. Several arguments suggest that nicotine is responsible for this protective effect via the nicotinic acetylcholine receptor (nAChR).

Nicotine may inhibit the penetration and spread of the virus and have a prophylactic effect in COVID-19 infection.

However, the epidemic is progressing throughout French territory and new variants (in particular the "English B1. 1.7 variant of SARS-COV-2") much more contagious run a risk of accelerating the epidemic in the population. The anti-SARS-COV-2 vaccines recently launched (or being evaluated) represent great hope in this health crisis, but trials were only able to show their effectiveness on symptomatic forms of SARS-COV-2 infection. On the one hand, the vaccination compaign for the entire population requires many months,which leaves many unprotected subjects waiting. In addition, there is currently no evidence of a protective role of vaccines against asymptomatic forms of COVID-19 and therefore on SARS-COV-2 transmission. Finally, the nicotine patches may protect people in hight-risk areas/periods until they are vaccinated (if they accept it and are eligible for it) and in the post-vaccination weeks necessary for the effectiveness of the vaccine,which reinforces the importance of evaluating this alternative prevention strategy, in the context of the arrival of vaccines
 
Efficacy of Nicotine in Preventing COVID-19 Infection (NICOVID-PREV)

https://clinicaltrials.gov/ct2/show/NCT04583410

The coronavirus disease (COVID-19) epidemic represents a major therapeutic challenge. The highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) and the long duration of the disease have led to a massive influx of patients admitted in health services and intensive care units.

According to current knowledge, there are no treatments that prevent the spread of the infection, especially in exposed populations, or the disease progression to a severe form.

Daily active smokers are infrequent among outpatients or hospitalized patients with COVID-19. Several arguments suggest that nicotine is responsible for this protective effect via the nicotinic acetylcholine receptor (nAChR).

Nicotine may inhibit the penetration and spread of the virus and have a prophylactic effect in COVID-19 infection.

However, the epidemic is progressing throughout French territory and new variants (in particular the "English B1. 1.7 variant of SARS-COV-2") much more contagious run a risk of accelerating the epidemic in the population. The anti-SARS-COV-2 vaccines recently launched (or being evaluated) represent great hope in this health crisis, but trials were only able to show their effectiveness on symptomatic forms of SARS-COV-2 infection. On the one hand, the vaccination compaign for the entire population requires many months,which leaves many unprotected subjects waiting. In addition, there is currently no evidence of a protective role of vaccines against asymptomatic forms of COVID-19 and therefore on SARS-COV-2 transmission. Finally, the nicotine patches may protect people in hight-risk areas/periods until they are vaccinated (if they accept it and are eligible for it) and in the post-vaccination weeks necessary for the effectiveness of the vaccine,which reinforces the importance of evaluating this alternative prevention strategy, in the context of the arrival of vaccines

Here is another good link, with footnotes to the science.

How To Neutralize Potential Damage From MRNA Vaccines

https://principia-scientific.com/how-to-neutralize-potential-damage-from-mrna-vaccines/

This info will become more and more sought after. People can still save themselves. I drink kudzu root tea every day just in case the guinea pigs are shedding.
 
I got aches and pains from the original covid back before the lockdowns even began for about 8 hours. I woke up that way called out of work, was better by late afternoon.
 
This is interesting discussion.
I have also inadvertently used MSM popularized names of the variants previously. However after reading more about naming issues, going forward to avoid any impact on business of Delta Airlines, might be best to use the term 'the variant" instead.
 
These work like chewing tobacco, except it's all contained in a pouch you can throw away and does not contain the ingredient in tobacco that causes mouth cancer. Just put it between your lip and gums for 10-20 minutes. Don't excessively swallow your saliva.

zyn_wintergreen_3_front_600x600.jpg

aclk


zyn_mini_us_2_1_2272e392-128c-46d2-a3d3-89fa9a351aee_1024x1024.jpg
 
Last edited:
Back
Top